Madrigal Pharmaceuticals, Inc. (MDGL)

Madrigal Pharmaceuticals Revenue

In the year 2025, Madrigal Pharmaceuticals had annual revenue of $958.40M with 432.05% growth. Madrigal Pharmaceuticals had revenue of $321.08M in the quarter ending December 31, 2025, with 210.77% growth.

• Revenue (ttm): $958.40M
• Revenue Growth: +432.05%
• P/S Ratio: 10.06
• Revenue / Employee: $1,047,435
• Employees: 915
• Market Cap: 9.73B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	958.40M	778.27M	432.05%
Dec 31, 2024	180.13M	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-
Dec 31, 2019	-	-	-
Dec 31, 2018	-	-	-
Dec 31, 2017	-	-	-
Dec 31, 2016	-	-	-
Dec 31, 2015	-	-	-
Dec 31, 2014	-	-	-
Dec 31, 2013	-	-	-
Dec 31, 2012	147.00K	-7.44M	-98.06%
Dec 31, 2011	7.58M	-7.22M	-48.77%
Dec 31, 2010	14.80M	-129.44M	-89.74%
Dec 31, 2009	144.25M	141.63M	5,416.06%
Dec 31, 2008	2.62M	1.87M	251.95%
Dec 31, 2007	743.00K	-	-
Dec 31, 2006	-	-	-
Dec 31, 2005	-	-	-